47 SEX- AND AGE SPECIFIC ASSOCIATION OF AF WITH MORTALITY IN COVID-19 Diabetes mellitus (type I or II) n (%) 1,494 (26.1) 1,211 (25.5) 188 (27.6) 9 (20.0) 130 (36.3) Peripheral arterial disease n (%) 271 (6.0) 199 (5.3) 54 (9.8) 6 (15.0) 22 (7.6) Myocardial infarctiona n (%) 523 (9.2) 397 (8.4) 81 (11.9) 6 (14.0) 57 (16.1) Renal impairment n (%) 620 (10.7) 447 (9.3) 123 (17.9) 4 (8.7) 73 (20.1) COPD n (%) 643 (11.1) 504 (10.5) 97 (14.1) 2 (4.3) 61 (16.8) Risk factors BMI in kg/m2 median (IQR) 27.5 (24.6-30.9) 27.5 (24.6-31.0) 27.2 (24.5-30.5) 25.2 (23.7-28.3) 27.6 (24.6-30.8) Medication Digoxin n (%) 112 (1.9) 52 (1.1) 58 (8.4) 1 (2.2) 10 (2.7) Anti-arrhythmic drugs - class I n (%) 28 (0.5) 14 (0.3) 12 (1.7) 0 (0.0) 2 (0.5) Anti-arrhythmic drugs - class III n (%) 110 (1.9) 68 (1.4) 24 (3.5) 4 (8.7) 17 (4.7) Anti-arrhythmic drugs - class IV n (%) 64 (1.1) 46 (1.0) 15 (2.2) 0 (0.0) 4 (1.1) Beta blockers n (%) 1,562 (27.0) 1,143 (23.8) 308 (44.5) 21 (45.7) 159 (43.7) Antihypertensive drugsb n (%) 2,575 (44.6) 1,994 (41.6) 397 (57.4) 30 (65.2) 244 (67.0) Platelet inhibitors n (%) 1,270 (22.0) 1,024 (21.3) 139 (20.1) 14 (30.4) 122 (33.5) Anticoagulants n (%) 779 (13.5) 444 (9.3) 284 (41.0) 10 (21.7) 101 (27.7) Antidiabetic drugs n (%) 1,105 (19.1) 898 (18.7) 141 (20.4) 6 (13.0) 95 (26.1) Physical examination, biomarkers (at the start of hospital admission) Temperature in °C median (IQR) 37.8 (37.0-38.5) 37.8 (37.0-38.5) 37.7 (37.0-38.5) 37.7 (37.1-37.9) 37.8 (36.9-38.6) C-reactive protein in mg/L median (IQR) 76.0 (31.0-144.0) 72.0 (28.0-140.0) 95.0 (45.0-170.0) 130.5 (43.8-271.3) 83.0 (39.0-139.0) White blood cell count x109/L median (IQR) 6.8 (5.0-9.3) 6.7 (5.0-9.2) 6.8 (5.0-9.9) 7.9 (6.1-10.9) 6.6 (5.0-9.6) a ST-elevation myocardial infarction or non-ST-elevation myocardial infarction. b Aldosterone antagonists, angiotensin II receptor blockers, angiotensin converting enzyme inhibitors, calcium channel blockers, diuretics. AF: atrial fibrillation; AFL: atrial flutter; AV: atrioventricular; BMI: body mass index; COPD: chronic obstructive pulmonary disease; IQR: interquartile range; n: number. 3
RkJQdWJsaXNoZXIy MTk4NDMw